BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16533284)

  • 1. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components.
    Krailadsiri P; Seghatchian J; Macgregor I; Drummond O; Perrin R; Spring F; Prescott R; Williamson L; Prowse C; Anstee D; Turner M
    Transfusion; 2006 Mar; 46(3):407-17. PubMed ID: 16533284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.
    Sowemimo-Coker SO; Demczyk CA; Andrade F; Baker CA
    Transfusion; 2010 May; 50(5):980-8. PubMed ID: 20003057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion reduction of red blood cells: impact on component quality.
    Wiltshire M; Thomas S; Scott J; Hicks V; Haines M; Cookson P; Garwood M; Cardigan R
    Transfusion; 2010 May; 50(5):970-9. PubMed ID: 19951322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
    Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
    Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.
    Fagge T; Barclay GR; Macgregor I; Head M; Ironside J; Turner M
    Transfusion; 2005 Apr; 45(4):504-13. PubMed ID: 15819670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of whole-blood storage time on the number of white cells and platelets in whole blood and in white cell-reduced red cells.
    van der Meer PF; de Wildt-Eggen J
    Transfusion; 2006 Apr; 46(4):589-94. PubMed ID: 16584435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.
    Thibault L; Beauséjour A; de Grandmont MJ; Lemieux R; Leblanc JF
    Transfusion; 2006 Aug; 46(8):1292-9. PubMed ID: 16934062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved leucoreduction of red blood cell units prepared after a 24-h hold with the platelet-rich plasma method using newly developed filters.
    Thibault L; Beauséjour A; Jacques A; de Grandmont MJ; Lemieux R; Grégoire Y; Ducas E; Boucher G
    Vox Sang; 2008 May; 94(4):286-91. PubMed ID: 18208406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
    Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
    Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
    Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
    Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underestimation of the expression of cellular prion protein on human red blood cells.
    Panigaj M; Brouckova A; Glierova H; Dvorakova E; Simak J; Vostal JG; Holada K
    Transfusion; 2011 May; 51(5):1012-21. PubMed ID: 21058954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
    Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
    Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
    Moog R
    J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent expression of cellular prion protein on blood cells of human and nonhuman primates.
    Holada K; Simak J; Brown P; Vostal JG
    Transfusion; 2007 Dec; 47(12):2223-32. PubMed ID: 17714417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside.
    Cardo LJ; Salata J; Harman R; Mendez J; Weina PJ
    Transfusion; 2006 Jun; 46(6):896-902. PubMed ID: 16734805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.